Covid Oximetry >
CVD - Cardiovascular Disease >
Digital Resources Hub >
Environmental Sustainability >
FeNO - Fractional exhaled nitric oxide - for the diagnosis and management of Asthma >
Health Inequalities >
Healthy Ageing >
Improving Health in Care Homes >
Industry and Innovation >
Innovation Insight >
Medicines Optimisation >
Mental Health >
National Programmes >
Nationally Prioritised Innovations >
NHS Insights Prioritisation Programme (NIPP) >
Patient Safety Collaborative >
Primary and Community Care Programme >
Q - Wessex >
Wessex Cancer Innovation Programme >
See all programmes >
Our Focus >
Engaging with Us >
See all workstreams >
For treatment of primary hypercholesterolaemia and mixed dyslipidaemia.
Two cost-effective drugs that significantly lower
If you'd like to discuss this Innovation, have an idea or a new Innovation, please get in touch.
Hi from Health Innovation Wessex 👋
Health Innovation Wessex is the new name for Wessex AHSN (from 1 October 2023).
Our name has changed, but our mission stays the same - we continue to drive the adoption and spread of innovation for a healthier Wessex.
Hear our latest news and updates by:
Signing up to our newsletter
Following us on X
Connecting with us on LinkedIn